• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

WellSpan Health Launches First Patient-Facing GenAI Healthcare Agent

by Fred Pennic 09/26/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
WellSpan Health Launches First Patient-Facing GenAI Healthcare Agent

What You Should Know: 

– WellSpan Health, a leading integrated healthcare provider known for its innovation, is partnering with Hippocratic AI, a pioneer in healthcare-focused large language models, to introduce a groundbreaking clinical GenAI healthcare agent. 

– The conversational AI-powered service will directly interact with patients, enhancing healthcare access, equity, and outcomes.

Improve Access and Health Screening for Patients

Hippocratic AI’s GenAI agent, designed for telephone communication, has already engaged with over 100 WellSpan patients this month, improving access to life-saving cancer screenings. This technology allows WellSpan to address care gaps in multilingual and underserved communities, scaling resources previously unavailable.

WellSpan has identified thousands of patients eligible for colorectal cancer screenings who have not yet undergone them. Hippocratic AI’s agent is enhancing access for those with language barriers or difficulties navigating the online patient portal, MyWellSpan. Plans are underway to expand language support to include Haitian Creole and Nepali.

The GenAI agent engages patients in comprehensive and empathetic conversations about their colorectal health, providing detailed transcripts to WellSpan clinicians for review. In some cases, the agent can transfer patients to a human clinician or facilitate follow-up calls.

Future Development

Future GenAI agents are being developed to support critical workflows like chronic care management, post-discharge follow-up for specific conditions, wellness surveys, health risk assessments, and pre-operative instructions.

“At WellSpan, we’re reimaging healthcare by tapping into innovation that supports our clinical teams, and we’re excited to introduce this cutting-edge technology for our patients in ways that also allow us to address health disparities,” said Kasey Paulus, senior vice president and chief nursing executive, WellSpan Health. “We’re committed to utilizing AI that’s designed to ensure patient safety continues to be our top priority and our collaboration in quality assurance with Hippocratic AI only strengthens that approach.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Generative AI, Large Languard Model (LLM)

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |